← Dashboard
Jul 23, 2026 01:35 AM ET
Signal
Korea
(LEAD) SAMSUNG BIOLOGICS Q2 NET RISES 29.1 PCT ON FULL-CAPACITY OPERATIONS, WEAK WON - YONHAP
Net rises 29.1% on full-capacity operations and weak won.
What changed
Net rises 29.1% on full-capacity operations and weak won.
Why it matters
Net rises 29.1% on full-capacity operations and weak won. — impact context not separately stored; see What changed.
Sources
yonhap
Related signals
SK HYNIX HOLDS GROUNDBREAKING CEREMONY FOR HBM PRODUCTION BASE IN US - KOREAHERALD →
MEET SK HYNIX, THE TRILLION-DOLLAR SOUTH KOREAN CHIPMAKER DEBUTING ON U.S. MARKETS - CNBC →
EXCLUSIVE: SK HYNIX IN TALKS WITH INTEL ABOUT DEAL TO MAKE MEMORY CHIPS IN US FOR THE FIRST TIME, SOURCES SAY - REUTERS →